| Role |
Name |
Disclosure |
Details |
| Author | Robert W Tolan Jr, MD, Chief of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine | GlaxoSmithKline MedImmune MedImmune Merck Novartis sanofi pasteur sanofi pasteur sanofi pasteur Tap | Details | | Coauthor | Marcelo Laufer, MD, Division of Pediatric Infectious Diseases, Attending, Miami Children's Hospital | Nothing to disclose | Details | | Medical Editor | Ashir Kumar, MBBS, MD, FAAP, Professor, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University; Consulting Staff, Department of Pediatrics, EW Sparrow Hospital | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | Managing Editor | Leslie L Barton, MD, Professor, Program Director, Department of Pediatrics, University of Arizona School of Medicine | Nothing to disclose | Details | | CME Editor | Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine | Nothing to disclose | Details | | Chief Editor | Russell W Steele, MD, Professor and Vice Chairman, Department of Pediatrics, Head, Division of Infectious Diseases, Louisiana State University Health Sciences Center | None | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Marcelo Laufer, Coauthor |
The contributor discloses no conflict of interest. |
|